New York, NY -- February 25, 2020 -- via NextBigTicker.com


Puration, Inc. (USOTC:PURA) opened up today from yesterday’s close as the PPS continues to show signs that it could potentially experience one of its historic periodic PPS surges.  PURA hit $0.09 last September after trading in the $0.04 range days prior.  Last March, PURA hit $0.15 after trading in the $0.06 range days prior.  Yesterday, PURA received a BUY recommendation from AmericanBulls, a BULLISH rating from BullishInvestor and a VERY BULLISH rating from StockTA.  Though the PPS did not see a strong increase yesterday, it did manage to maintain its $0.03 range and not lose any ground in one of the biggest market wide down day performances in the last two years.  With the market recovering today from yesterday’s COVID-19 reaction, PURA is again well positioned to see the PPS continue to climb.

The PURA PPS recently experienced a retrace from just shy of $0.05 to $0.03.  The retrace was a healthy consolidation with less than half the volume of the climb the week earlier.  PURA is showing clear signs that is ready to restart one if its periodic breakout climbs that could see the PPS run back to its $0.15 52-week high.  A PURA PPS accelerated climb could be triggered at any moment news from the company’s recently launched acquisition campaign.

MarketWatch

“U.S. stocks rallied at the market open Tuesday as investors attempted to assess growing headwinds like the spread of COVID-19 outside China against the backdrop of positive economic growth.

Global stocks were hammered Monday, with the Dow Jones Industrial Average and S&P 500 index charting their biggest one-day percentage losses in more than two years.”

PURA has recently launched an acquisition campaign fueled by a $5 million investment.  The company has announced that it expects to close the acquisition of a CBD Infused Pet Products operation later this week.

Analyst Speculative Buy and $0.35 PPS Target
 

PURA recently announced a next iteration of an ongoing CBD consumer survey conducted by Goldman Research on behalf of PURA to gauge and refine the company’s ongoing approach to the CBD consumer market. 

The Goldman CBD consumer survey included a PURA speculative BUY recommendation and at $0.35 target PPS.  PURA closed yesterday at $0.29.  Realizing the target PPS could deliver a 1000% ROI. 

The full CBD consumer survey update can be viewed at GOLDMAN CBD SURVEY.

Other cannabis stocks that appear to be enjoying today’s rally include Hemp (HEMP), Medical Marijuana (MJNA) and KushCo Holdings, (KSHB).

Disclaimer: 

NextBigTicker.com (NBT)is a third party publisher and news dissemination service provider. NBT is NOT affiliated in any manner with any company mentioned herein. NBT is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. NBT's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. NBT is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. NBT has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

Source: www.nextbigticker.com

Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Medical Marijuana (PK) Charts.
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Medical Marijuana (PK) Charts.